Johnson Chemical Pharmaceutical Works Co., Ltd.

TPEX:4747 Stock Report

Market Cap: NT$3.3b

Johnson Chemical Pharmaceutical Works Past Earnings Performance

Past criteria checks 2/6

Johnson Chemical Pharmaceutical Works has been growing earnings at an average annual rate of 5.9%, while the Pharmaceuticals industry saw earnings growing at 8.2% annually. Revenues have been growing at an average rate of 9.5% per year. Johnson Chemical Pharmaceutical Works's return on equity is 4.9%, and it has net margins of 13.2%.

Key information

5.9%

Earnings growth rate

0.06%

EPS growth rate

Pharmaceuticals Industry Growth18.5%
Revenue growth rate9.5%
Return on equity4.9%
Net Margin13.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Could Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) Have The Makings Of Another Dividend Aristocrat?

Mar 25
Could Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) Have The Makings Of Another Dividend Aristocrat?

These 4 Measures Indicate That Johnson Chemical Pharmaceutical Works (GTSM:4747) Is Using Debt Reasonably Well

Feb 18
These 4 Measures Indicate That Johnson Chemical Pharmaceutical Works (GTSM:4747) Is Using Debt Reasonably Well

Weak Financial Prospects Seem To Be Dragging Down Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) Stock

Feb 01
Weak Financial Prospects Seem To Be Dragging Down Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) Stock

Estimating The Fair Value Of Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747)

Jan 12
Estimating The Fair Value Of Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747)

Is Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) An Attractive Dividend Stock?

Dec 25
Is Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) An Attractive Dividend Stock?

Johnson Chemical Pharmaceutical Works (GTSM:4747) Is Growing Earnings But Are They A Good Guide?

Dec 07
Johnson Chemical Pharmaceutical Works (GTSM:4747) Is Growing Earnings But Are They A Good Guide?

Revenue & Expenses Breakdown

How Johnson Chemical Pharmaceutical Works makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

TPEX:4747 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 246188213317
30 Jun 246167813418
31 Mar 246217813220
31 Dec 236078012917
30 Sep 235938112417
30 Jun 235728312117
31 Mar 235337511414
31 Dec 224956510913
30 Sep 224605910311
30 Jun 22434531009
31 Mar 2241651999
31 Dec 21411491019
30 Sep 214085010210
30 Jun 214135110412
31 Mar 214125610513
31 Dec 204246410313
30 Sep 204457210313
30 Jun 204387110211
31 Mar 204426810311
31 Dec 194256410310
30 Sep 194116110210
30 Jun 194105910310
31 Mar 19412591019
31 Dec 1841257999
30 Sep 1840554968
30 Jun 1840758967
31 Mar 1840258967
31 Dec 1739560967
30 Sep 1739662977
30 Jun 1738158958
31 Mar 1738260958
31 Dec 16392639710
30 Sep 16392679611
30 Jun 16395709713
31 Mar 16390679617
31 Dec 15380629716
30 Sep 15366559814
30 Jun 15370629713
31 Mar 15365689416
31 Dec 14362729415
30 Sep 14363838815
30 Jun 14343748813
31 Mar 1432869906

Quality Earnings: 4747 has high quality earnings.

Growing Profit Margin: 4747's current net profit margins (13.2%) are lower than last year (13.6%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 4747's earnings have grown by 5.9% per year over the past 5 years.

Accelerating Growth: 4747's earnings growth over the past year (1.5%) is below its 5-year average (5.9% per year).

Earnings vs Industry: 4747 earnings growth over the past year (1.5%) did not outperform the Pharmaceuticals industry 11.9%.

Return on Equity

High ROE: 4747's Return on Equity (4.9%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 02:37
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Johnson Chemical Pharmaceutical Works Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Regina LeeCapital Securities Corporation